Managed Healthcare Executive Releases 2022 State of the Industry Survey
Respondents expressed middling optimism towards improvements to the American healthcare industry in 2022, according to Managed Healthcare Executive’s 2022 State [...]
On Medicare Limiting Coverage for Alzheimer’s Drug
Biogen’s outrageous original price for Aduhelm, $56,000 per year, is the poster child for how dysfunctional our drug pricing system [...]
Health care: ‘We will see more and more specialty drugs,’ Cigna CEO says
Cigna CEO David Cordani joined Yahoo Finance’s Anjalee Khemlani to discuss access to health care, innovation in therapeutics, and drug [...]
Medicare to limit coverage of contentious Alzheimer’s drug – Politico
With help from Megan R. Wilson and Katherine Ellen Foley Editor’s Note: POLITICO Pulse is a free version of POLITICO [...]
McDermott 2022 Health Policy Outlook
McDermott 2022 Health Policy Outlook As we start a new year and new congressional session, we are taking a look [...]
ISPOR Webinar: The Future of Biosimilars
Biosimilars are poised to increase access to otherwise expensive therapies, but legal and regulatory hurdles abound. In an ISPOR webinar [...]
Year in Review: Real-world Evidence in 2021
The Evidence Base rang in the new year with a look back at the real-world evidence (RWE) landscape of 2021. [...]
Healthcare Consulting Services Market by Type of Service (Digital Health, IT, Operations, Strategy, Financial, Hr & Talent), End User (Government Bodies, Healthcare Providers, Pharmaceutical & Biotechnology Companies), and Region – Global Forecasts to 2
Global healthcare consulting services market is projected to grow at CAGR of 11.5%” The global healthcare consulting services market is [...]
EQRx Enters Memorandum of Understanding with CVS Health to Create Cost Savings and Improve Patient Access to Innovative Medicines Seite 1 – 10.01.2022
The two companies will explore opportunities for a long-term, strategic partnership spanning the CVS Health enterprise Includes CVS Caremark, the [...]
Roche introduces cobas infinity edge, a new open digital ecosystem for point of care professionals, driving improved patient outcomes and operational efficiencies in healthcare
Roche’s new cloud-based platform connects patient test results, medical records and third-party applications, allowing professionals to monitor patients’ health, adjust [...]
Sarah Evanega pioneers visionary grassroots model for science communication
On Jan. 7, Sarah Evanega stepped down as director of the Alliance for Science to assume a new position at [...]
RWE in Pharma Interview Series: Clare Hague
Clare Hague, EMEA Therapeutic Area Market Access Leader at Janssen, was featured in The Evidence Base’s RWE in Pharma series [...]
Pharmacy Outlook: Sheila Arquette, NASP
Specialty pharmacies support patients diagnosed with life-altering and oftentimes life threatening complex health conditions, including cancer, rheumatoid arthritis, multiple sclerosis, [...]
Medifakt, unleashing Blockchain’s potential for the healthcare industry
It is an enterprise-grade blockchain platform tailored to the healthcare sector’s regulatory, operational, and market needs TALLINN, ESTONIA, January 9, [...]
Orchard Therapeutics Announces Recent Commercial and Regulatory Progress for Late-stage HSC Gene Therapy Programs and Outlines Key 2022 Milestones
Launch Momentum Building for Libmeldy ® in Europe with Health Technology Assessments Progressing Favorably and Treatment Underway for Multiple Commercial [...]
Case Study: MMIT’s Analytics Platform Saves Time and Resources for Healthcare Services Company
MMIT has released a case report detailing how its MMIT Analytics platform helped one healthcare services company save time and [...]
STAT Health Tech: Healthcare Mergers and Acquisitions on the Rise
Several healthcare and biotech mergers and acquisitions (M&A) have been announced in recent months, according to the latest STAT Health [...]
IBM Makes Another Attempt to Sell Watson Health
IBM is once again trying to sell IBM Watson Health with aims to make more than $1 billion. This comes [...]
Draft Ruling from CMS Suggests Narrow Coverage for Aduhelm
The Centers for Medicare & Medicaid Services (CMS) have released a draft ruling indicating it will only cover Biogen’s Alzheimer’s [...]
Upcoming Webinar: Getting Real with Real-World Evidence
Fierce Pharma and Databricks are hosting a webinar at 12 pm ET / 9 am PT, on Thursday, January 27th, [...]
2022 Dealmakers’ Intentions Survey Released
Syneos Health Consulting has released the results of its 2022 Dealmakers’ Intentions Survey. The survey’s finding indicated that IPO markets [...]
Amgen and Arrakis Therapeutics Announce Partnership to Develop RNA-targeting Oral Drugs
The biotech startup Arrakis Therapeutics has partnered with Amgen in a research collaboration to develop oral drugs that target disease-related [...]
Pfizer Shifts to Virtual Meetings and Cuts Sales Staff
Pfizer will lay off sales staff as they pivot towards virtual sales meetings with providers to adjust to changing provider [...]
Market Access Speed Makes the Differences for Pharma
Advances in science and legislative changes have accelerated drug discovery and approval in recent years. However, payers eye these drugs [...]
Pfizer, GSK and Teva lead 2022’s round of January drug price hikes: GoodRx
Pfizer, GSK and Teva lead 2022's round of January drug price hikes: GoodRx fkansteiner Tue, 01/04/2022 - 11:30 Read the [...]